appScorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Aurobindo Pharma Ltd
AUROPHARMA
Price Chart
Scorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Decreased Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has decreased by 1.46%
Recent NewsAll news
Aurobindo Pharma shares up 1.23% as Nifty gains
14 hours ago•Economic Times
Share price of Aurobindo Pharma falls as Nifty strengthens
2 days ago•Economic Times
Share price of Aurobindo Pharma falls as Nifty weakens
3 days ago•Economic Times
Recent EventsAll events
Press Release
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 30, 2023, titled "Press Release on signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis (PrEP).". | Download
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 30, 2023, titled "Press Release on signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis (PrEP).". | Download
Trading Window
Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Cash Dividend
Interim 1 • Div/Share: ₹ 3
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant